GT BIOPHARMA, INC. Increase (Decrease) in Prepaid Expense
GT BIOPHARMA, INC. (GTBP) reported Increase (Decrease) in Prepaid Expense of -$631.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-14
- GT BIOPHARMA, INC. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was -$409.00K, a 292.02% decline year-over-year.
- GT BIOPHARMA, INC. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was -$222.00K, a 1950.00% decline year-over-year.
- GT BIOPHARMA, INC. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$499.00K.
- GT BIOPHARMA, INC. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was -$103.00K, a 144.59% decline year-over-year.
- GT BIOPHARMA, INC. increase (decrease) in prepaid expense for fiscal 2025 was -$377.00K, a 462.50% decline from fiscal 2024.
- GT BIOPHARMA, INC. increase (decrease) in prepaid expense for fiscal 2024 was $104.00K, a 395.24% increase from fiscal 2023.
- GT BIOPHARMA, INC. increase (decrease) in prepaid expense for fiscal 2023 was $21.00K.
- GT BIOPHARMA, INC. increase (decrease) in prepaid expense for fiscal 2021 was -$174.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 3 month as first filed | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$409.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$631.00K 10-Q · filed 2026-08-14 | -$1.13M derived: sum of 3 quarters · filed 2026-08-14 | -$1.23M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | -$222.00K 10-Q · filed 2026-05-15 | -$721.00K derived: sum of 2 quarters · filed 2026-05-15 | -$824.00K derived: sum of 3 quarters · filed 2026-05-15 | -$611.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$499.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02 | -$602.00K derived: sum of 2 quarters · filed 2026-03-06 | -$389.00K derived: sum of 3 quarters · filed 2026-08-14 | -$377.00K 10-K · filed 2026-03-02 | ||
| 2025-09-30 | -$103.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-06 | $110.00K derived: sum of 2 quarters · filed 2026-08-14 | $122.00K 10-Q/A · filed 2026-03-06 | $62.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $213.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $225.00K 10-Q · filed 2026-08-14 | $165.00K derived: sum of 3 quarters · filed 2026-08-14 | $396.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $12.00K 10-Q · filed 2026-05-15 | -$48.00K derived: sum of 2 quarters · filed 2026-05-15 | $183.00K derived: sum of 3 quarters · filed 2026-05-15 | $122.00K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$60.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02 | $171.00K derived: sum of 2 quarters · filed 2026-03-06 | $110.00K derived: sum of 3 quarters · filed 2026-03-06 | $104.00K 10-K · filed 2026-03-02 | ||
| 2024-09-30 | $231.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2026-03-06 | $170.00K derived: sum of 2 quarters · filed 2026-03-06 | $164.00K 10-Q/A · filed 2026-03-06 | $201.00K derived: sum of 4 quarters · filed 2026-03-06 | ||
| 2024-06-30 | -$61.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2026-03-06 | -$67.00K 10-Q/A · filed 2026-03-06 | -$30.00K derived: sum of 3 quarters · filed 2026-03-06 | -$41.00K derived: sum of 4 quarters · filed 2026-03-06 | ||
| 2024-03-31 | -$6.00K 10-Q · filed 2025-05-15 | $31.00K derived: sum of 2 quarters · filed 2025-05-15 | $20.00K derived: sum of 3 quarters · filed 2025-05-15 | $31.00K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $26.00K derived: sum of 2 quarters · filed 2025-02-21 | $37.00K derived: sum of 3 quarters · filed 2025-02-21 | $21.00K 10-K · filed 2025-02-21 | ||
| 2023-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | -$16.00K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$5.00K 10-Q · filed 2024-08-14 | ||||
| 2023-03-31 | -$16.00K 10-Q · filed 2024-05-15 | |||||
| 2022-09-30 | -$134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$365.00K derived: sum of 2 quarters · filed 2023-11-01 | -$102.00K 10-Q · filed 2023-11-01 | $3.00K derived: sum of 4 quarters · filed 2023-11-01 | ||
| 2022-06-30 | -$231.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $32.00K 10-Q · filed 2023-08-07 | $137.00K derived: sum of 3 quarters · filed 2023-08-07 | $160.00K derived: sum of 4 quarters · filed 2023-08-07 | ||
| 2022-03-31 | $263.00K 10-Q · filed 2023-05-15 | $368.00K derived: sum of 2 quarters · filed 2023-05-15 | $391.00K derived: sum of 3 quarters · filed 2023-05-15 | $365.00K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $128.00K derived: sum of 2 quarters · filed 2022-10-31 | $102.00K derived: sum of 3 quarters · filed 2022-10-31 | -$174.00K 10-K · filed 2022-03-28 | ||
| 2021-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-31 | -$3.00K derived: sum of 2 quarters · filed 2022-10-31 | -$279.00K 10-Q · filed 2022-10-31 | |||
| 2021-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$302.00K 10-Q · filed 2022-08-15 | $302.00K 10-Q · filed 2021-08-23 | |||
| 2021-03-31 | -$276.00K 10-Q · filed 2022-05-16 | $276.00K 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | -$242.00K 10-K · filed 2022-03-28 | |||||
| 2020-06-30 | $63.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2021-12-29 | $126.00K 10-Q/A · filed 2021-12-29 | ||||
| 2020-03-31 | $63.00K 10-Q · filed 2021-05-17 | |||||
| 2019-12-31 | $216.00K 10-K · filed 2021-04-16 | |||||
| 2018-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $30.00K 10-K · filed 2020-03-27 | ||||
| 2018-09-30 | -$15.00K 10-Q · filed 2018-11-14 | |||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $0.00 10-K · filed 2019-03-29 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |